Much of Chris’ practice involves working closely with SMEs, often born out of promising academic research by major UK universities, helping them to develop effective intellectual property strategies and secure multi-million pound investments. He also works with in-house patent attorneys and senior executives at major multinationals, and has expertise in worldwide patent prosecution.
Chris has particular experience in relation to fuel cell technologies, mobile phone antennas, metal coatings, oil and gas exploration, medical devices, civil engineering, electronic article surveillance and endoscopy.
After taking his first degree in natural sciences and a postgraduate diploma in computer science at Christ’s College Cambridge, Chris entered the profession directly in 1991, training with a large private practice firm in London. He qualified in 1995, and joined HGF as a partner in 1999.
Chris is fluent in German, and is experienced in acting before the Opposition and Appeal Divisions of the European Patent Office in Munich.
Chris heads the Engineering team in HGF's Leeds office, and serves as Chair of HGF's Conflicts Committee.
Natural Sciences (Cantab)
Postgraduate Diploma in Computer Science (Cantab)
Postgraduate Certificate in Intellectual Property Law (London)
Intellectual Property Litigation Certificate
Chris regularly leads tutorials, both in-house and externally, for trainee patent attorneys preparing for UK and European qualifying examinations.
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.